CADESS.AI

Most Innovative Medical Technology Development Company 2022
Winners image
<p>Both inter-and intra-observer grading variations of prostate biopsies can be as high as 30-40%, even among experienced pathologists. This often leads to overly aggressive treatment. In contrast to existing solutions, CADESS analyzes prostate biopsies on the glandular level, identifying the malignancy grades of individual glands. This approach is highly accurate and enables visual confirmation of the results by a color-coded map of the glands, each color representing one malignancy grade. </p>